<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d566">
    <sentence id="DDI-DrugBank.d566.s0" text="Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.">
        <entity id="DDI-DrugBank.d566.s0.e0" charOffset="0-13"
            type="drug" text="Cholestyramine"/>
        <entity id="DDI-DrugBank.d566.s0.e1" charOffset="15-19"
            type="group" text="resin"/>
        <entity id="DDI-DrugBank.d566.s0.e2" charOffset="95-108"
            type="group" text="phenylbutazone"/>
        <entity id="DDI-DrugBank.d566.s0.e3" charOffset="111-118"
            type="drug" text="warfarin"/>
        <entity id="DDI-DrugBank.d566.s0.e4" charOffset="121-138"
            type="group" text="thiazide diuretics"/>
        <entity id="DDI-DrugBank.d566.s0.e5" charOffset="152-162"
            type="drug" text="propranolol"/>
        <entity id="DDI-DrugBank.d566.s0.e6" charOffset="184-195"
            type="drug" text="tetracycline"/>
        <entity id="DDI-DrugBank.d566.s0.e7" charOffset="197-208"
            type="drug" text="penicillin G"/>
        <entity id="DDI-DrugBank.d566.s0.e8" charOffset="211-223"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d566.s0.e9" charOffset="238-246"
            type="drug" text="thyroxine"/>
        <entity id="DDI-DrugBank.d566.s0.e10" charOffset="262-270"
            type="group" text="estrogens"/>
        <entity id="DDI-DrugBank.d566.s0.e11" charOffset="276-285"
            type="group" text="progestins"/>
        <entity id="DDI-DrugBank.d566.s0.e12" charOffset="292-300"
            type="group" text="digitalis"/>
        <ddi id="DDI-DrugBank.d566.s0.d0" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e2" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d1" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e3" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d2" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e4" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d3" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e5" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d4" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e6" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d5" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e7" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d6" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e8" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d7" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e9" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d8" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e10" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d9" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e11" type="mechanism"/>
        <ddi id="DDI-DrugBank.d566.s0.d10" e1="DDI-DrugBank.d566.s0.e0"
            e2="DDI-DrugBank.d566.s0.e12" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d566.s1" text="Interference with the absorption of oral phosphate supplements has been observed with another positively-charged bile acid sequestrant.">
        <entity id="DDI-DrugBank.d566.s1.e0" charOffset="41-49"
            type="drug_n" text="phosphate"/>
    </sentence>
    <sentence id="DDI-DrugBank.d566.s2" text="Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.">
        <entity id="DDI-DrugBank.d566.s2.e0" charOffset="0-13"
            type="drug" text="Cholestyramine"/>
        <entity id="DDI-DrugBank.d566.s2.e1" charOffset="15-19"
            type="group" text="resin"/>
        <entity id="DDI-DrugBank.d566.s2.e2" charOffset="132-145"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d566.s2.e3" charOffset="147-151"
            type="group" text="resin"/>
        <entity id="DDI-DrugBank.d566.s2.e4" charOffset="219-227"
            type="group" text="digitalis"/>
        <entity id="DDI-DrugBank.d566.s2.e5" charOffset="300-313"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d566.s2.e6" charOffset="315-319"
            type="group" text="resin"/>
        <ddi id="DDI-DrugBank.d566.s2.d0" e1="DDI-DrugBank.d566.s2.e2"
            e2="DDI-DrugBank.d566.s2.e4" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d566.s3" text="Because cholestyramine binds bile acids, cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat soluble vitamins such as A, D, E, and K.">
        <entity id="DDI-DrugBank.d566.s3.e0" charOffset="8-21"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d566.s3.e1" charOffset="41-54"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d566.s3.e2" charOffset="56-60"
            type="group" text="resin"/>
        <entity id="DDI-DrugBank.d566.s3.e3" charOffset="152-171"
            type="group" text="fat soluble vitamins"/>
    </sentence>
    <sentence id="DDI-DrugBank.d566.s4" text="When cholestyramine resin is given for long periods of time, concomitant supplementation with water-miscible (or parenteral) forms of fat-soluble vitamins should be considered.">
        <entity id="DDI-DrugBank.d566.s4.e0" charOffset="5-18"
            type="drug" text="cholestyramine"/>
        <entity id="DDI-DrugBank.d566.s4.e1" charOffset="20-24"
            type="group" text="resin"/>
        <entity id="DDI-DrugBank.d566.s4.e2" charOffset="134-153"
            type="group" text="fat-soluble vitamins"/>
    </sentence>
    <sentence id="DDI-DrugBank.d566.s5" text="SINCE CHOLESTYRAMINE RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.">
        <entity id="DDI-DrugBank.d566.s5.e0" charOffset="6-19"
            type="drug" text="CHOLESTYRAMINE"/>
        <entity id="DDI-DrugBank.d566.s5.e1" charOffset="21-25"
            type="group" text="RESIN"/>
        <entity id="DDI-DrugBank.d566.s5.e2" charOffset="162-175"
            type="drug" text="CHOLESTYRAMINE"/>
        <entity id="DDI-DrugBank.d566.s5.e3" charOffset="177-181"
            type="group" text="RESIN"/>
    </sentence>
</document>
